BlueRock Therapeutics to start cell therapy trial for Parkinson’s disease
BlueRock Therapeutics is all set to initiate Phase I Study of MSK-DA01 Cell Therapy for advanced Parkinson’s disease (PD) after…
BlueRock Therapeutics is all set to initiate Phase I Study of MSK-DA01 Cell Therapy for advanced Parkinson’s disease (PD) after…
Ionis Pharmaceuticals has initiated a Phase III clinical trial of antisense medicine ION363 in patients with amyotrophic lateral sclerosis (ALS)…
Roche has decided to discontinue dosing in the Phase III GENERATION HD1 study of investigational antisense therapy, tominersen, in manifest Huntington’s disease (HD). Licensed from…
The Australian Government is launching a competitive grant round of $11.6m (A$15m) to kick-start clinical trials to develop treatments for mental illness. The A$15m Innovative…
Biotechnology company Pinteon Therapeutics has announced results from its Phase I study of novel tau antibody, PNT001, in treating neurodegenerative…
Concert Pharmaceuticals has announced that its Phase II clinical trial of CTP-692 as an adjunctive treatment in patients with schizophrenia…
Clinical-stage pharma company Apnimed has announced the dosing of the first patient in a Phase II clinical trial of its…
Clinical-stage biopharma firm Seelos Therapeutics has dosed the first patients in its registrational 'Proof of Concept' study to evaluate SLS-002…
With Eli Lilly’s donanemab and Biogen’s aducanumab jockeying for position in the race for key regulatory approvals, the so-called amyloid…
The top tweeted terms are the trending industry discussions happening on Twitter by key individuals (influencers) as tracked by the…
Strategikon Pharma announced a global update for its Clinical Maestro™ platform that advances capabilities for tracking out of scope services…
To facilitate virtual TMF inspections and improve efficiency, the European Medicines Agency (EMA) encourages sponsors to provide inspectors direct system…
Translation software is essential for performing high-quality translation, especially in the clinical trial and medical field, as it facilitates and…